Titelia

Funds holding Chunghwa Chemical Synthesis & Biotech Co Ltd

ISIN TW0001762003 · Taiwan

Fund holders
5
Of which ETFs
4 1 other fund
Value held
436.5K $
FundSharesValueWeight in fund
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 359,000319.9K $0.00 %as of Apr 30, 2026 ↗
Avantis Emerging Markets Equity ETF American Century ETF Trust 98,00084.9K $0.00 %as of Feb 28, 2026 ↗
Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust 21,00018.7K $0.00 %as of Apr 30, 2026 ↗
Avantis Emerging Markets Value ETF American Century ETF Trust 14,00012.1K $0.00 %as of Feb 28, 2026 ↗
Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust 1,000866.3 $0.00 %as of Feb 28, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Avantis Emerging Markets Value ETF American Century ETF Trust 0.00 %as of Feb 28, 2026 ↗
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
Avantis Emerging Markets Equity ETF American Century ETF Trust 0.00 %as of Feb 28, 2026 ↗
Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust 0.00 %as of Feb 28, 2026 ↗
Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q25-1493,000-11.2 %
2026Q160555,0000.0 %
2025Q46-1555,000-45.2 %
2025Q37-31,012,169-11.5 %
2025Q210-21,143,169-9.6 %
2025Q112-41,264,169-9.6 %
2024Q416-11,399,169-2.4 %
2024Q317-21,433,892+0.8 %
2024Q219+11,422,892+6.8 %
2024Q118+31,331,892-0.3 %
2023Q4151,335,892
Cite this page

Titelia. "Funds holding Chunghwa Chemical Synthesis & Biotech Co Ltd". https://titelia.com/en/stocks/chunghwa-chemical-synthesis-biotech-co-ltd-TW0001762003